Beijing Municipal Key Laboratory of Clinical Epidemiology, School of Public Health, Capital Medical University, Beijing 100069, China.
Centre for Precision Health, Edith Cowan University, Perth 6027, Australia.
J Clin Endocrinol Metab. 2022 May 17;107(6):e2365-e2372. doi: 10.1210/clinem/dgac110.
Subclinical hypothyroidism is known to increase the risk of cardiovascular diseases and mortality. However, the longitudinal association between subclinical hypothyroidism and incident metabolic syndrome remains unclear.
A total of 3615 participants from Beijing Health Management Cohort were enrolled from 2012 to 2014 and followed through 2019. People were placed into subclinical hypothyroidism and euthyroidism groups according to serum-free thyroxine and TSH concentrations. We used Cox proportional hazards regression models to investigate the relationship between TSH level and incident metabolic syndrome considering the modification effect of sex and age.
Of 3615 participants, 1929 were men (53.4%); mean (SD) age was 43.51 (11.73) years. Throughout the follow-up (median [interquartile range], 3.0 [2.8-3.2] years), 738 individuals developed metabolic syndrome. Subclinical hypothyroidism was significantly associated with metabolic syndrome development only in men, and the adjusted hazard ratio was 1.87 (95% CI, 1.21-2.90) compared with euthyroidism group. Of note, there was no increased risk of metabolic syndrome in people aged 50 years or older with subclinical hypothyroidism.
Subclinical hypothyroidism is associated with incident metabolic syndrome in young men. Further studies are needed to evaluate the targeted threshold and benefit of thyroid hormone replacement therapy for metabolic health.
亚临床甲状腺功能减退症已知会增加心血管疾病和死亡率的风险。然而,亚临床甲状腺功能减退症与代谢综合征事件之间的纵向关联仍不清楚。
共有 3615 名来自北京健康管理队列的参与者于 2012 年至 2014 年入选,并随访至 2019 年。根据血清游离甲状腺素和 TSH 浓度,将人群分为亚临床甲状腺功能减退症和甲状腺功能正常组。我们使用 Cox 比例风险回归模型,考虑性别和年龄的修饰作用,研究 TSH 水平与代谢综合征事件之间的关系。
在 3615 名参与者中,有 1929 名男性(53.4%);平均(SD)年龄为 43.51(11.73)岁。在整个随访期间(中位数[四分位距],3.0[2.8-3.2]年),738 人发生代谢综合征。亚临床甲状腺功能减退症仅与男性代谢综合征的发生显著相关,与甲状腺功能正常组相比,调整后的危险比为 1.87(95%可信区间,1.21-2.90)。值得注意的是,年龄在 50 岁或以上的亚临床甲状腺功能减退症患者发生代谢综合征的风险没有增加。
亚临床甲状腺功能减退症与年轻男性代谢综合征的发生有关。需要进一步的研究来评估针对代谢健康的甲状腺激素替代治疗的目标阈值和获益。